|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Prepaid expenses | ||||||||||||
| Other current assets | ||||||||||||
| Current portion of investments in U.S. Treasury securities, net | ||||||||||||
| Investments | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Non-current portion of investments in U.S. Treasury securities, net | ||||||||||||
| Long-term investment | ||||||||||||
| Restricted cash | ||||||||||||
| Investments | ||||||||||||
| Property and equipment, net | ||||||||||||
| Lease right-of-use assets - finance | ||||||||||||
| Lease right-of-use assets - operating | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and Stockholders' equity | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Taxes payable | ||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||
| Accrued bonuses | ||||||||||||
| Convertible SAFE note, net | ||||||||||||
| Current portion of lease liabilities - finance | ||||||||||||
| Current portion of lease liabilities - operating | ||||||||||||
| Total current liabilities | ||||||||||||
| Non-current liabilities | ||||||||||||
| Non-current portion of lease liabilities - finance | ||||||||||||
| Non-current portion of lease liabilities - operating | ||||||||||||
| Total liabilities | ||||||||||||
| Convertible preferred stock | ||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||
| Stockholders' equity: | ||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized as of June 30, 2026; 78,622,870 shares issued and 78,622,604 shares outstanding as of June 30, 2026; 500,000,000 shares authorized as of December 31, 2025; 73,001,766 shares issued and 73,001,350 shares outstanding as of December 31, 2025 | ||||||||||||
| Treasury stock, at cost, 3,827 common shares as of June 30, 2026 and as of December 31, 2025 | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated other comprehensive gain (loss) | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' equity | ||||||||||||
| Total liabilities and stockholders' equity |
Loading...
